Physician profile
Steve Eng
NPI 1780627141
$14,034.44
in general payments reported to CMS, 2019-2025
33 companies · $1,730 in 2025
The $1,730 reported for 2025 was more than what 81% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,503 · 2020: $891 · 2021: $3,240 · 2022: $1,534 · 2023: $2,290 · 2024: $2,847 · 2025: $1,730.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,161 · Travel and Lodging: $1,706.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,160.71 |
| Travel and Lodging | $1,706.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $5,507.21 | 2019-2024 | Portfolio, Hammertube Sterile Implant Kits |
| Stryker Corporation | $1,938.04 | 2019-2025 | Citrefix, Prostep Mica, Prostep |
| Integra Lifesciences Corporation | $1,801.65 | 2019-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Biotissue Holdings INC. | $1,649.99 | 2022-2025 | |
| Smith+Nephew, INC. | $720.69 | 2019-2025 | Stravix, Collagenase Santyl, Renasys Touch |
| Acera Surgical, INC. | $236.89 | 2019-2025 | Restrata Wound Matrix |
| Tactile Systems Technology INC | $233.91 | 2019-2024 | Entre Plus, Flexitouch Plus |
| Wright Medical Technology, INC. | $223.18 | 2020 | |
| Treace Medical Concepts, INC. | $192.23 | 2022-2025 | |
| Zimmer Biomet Holdings, INC. | $170.80 | 2019-2021 | |
| Horizon Therapeutics Plc | $165.15 | 2019-2020 | |
| Depuy Synthes Sales INC. | $153.65 | 2019-2024 | Crosstie |
| Inari Medical, INC. | $123.26 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Paratek Pharmaceuticals, INC. | $118.55 | 2022-2025 | Nuzyra |
| Aroa Biosurgery Incorporated | $86.55 | 2020-2025 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polynovo North America LLC | $83.27 | 2023-2024 | Novosorb Btm |
| Zyla Life Sciences, INC. | $74.31 | 2019-2020 | |
| Derma Sciences, INC. | $60.90 | 2019 | |
| Abbvie INC. | $53.10 | 2022-2023 | |
| Access Pro Medical, LLC | $51.65 | 2025 | Matriderm |
| Abbott Laboratories | $43.99 | 2023 | Eterna, Proclaim |
| Globus Medical, INC. | $43.79 | 2021 | |
| Sandoz INC. | $42.52 | 2019-2020 | |
| Tei Medical INC. | $36.60 | 2019 | |
| Nabriva Therapeutics, Plc | $33.67 | 2020-2021 | |
| Trilliant Surgical LLC. | $32.57 | 2023 | Arsenal Ankle 10 Hole 1/3 Tubular Plate, Arsenal Sinus Support Plate |
| Vertex Pharmaceuticals Incorporated | $32.51 | 2025 | |
| Organogenesis INC. | $26.87 | 2021 | |
| Resmed Corp | $25.86 | 2022 | |
| Arthrosurface Incorporated | $25.72 | 2020 | |
| Nevro Corp. | $16.22 | 2022 | |
| Acell, INC. | $15.75 | 2019 | |
| Merck Sharp & Dohme LLC | $13.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steve Eng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.